manufacturing, marketing and distribution of medicines, healthcare products and branded genericsProduct Profile: Company has an extensive basket of 50 Brands (125 products) with a portfolio contributing to 10 therapeutic areas, covering multiple dosage forms like Tablets, Capsules, Oral Liquids, Ointments and Injectables.
Gujarat Terce Laboratories Limited shareholders have approved the re-appointment of Mr. Aalap Prajapati as Managing Director & CEO for a three-year term, effective from 28 October 2026 to 27 October 2029. Mr. Prajapati brings over 15 years of pharmaceutical experience, specializing in business strategy, operations, and development. His continued leadership...
Gujarat Terce Laboratories has clarified an earlier announcement regarding the re-appointment of its Managing Director & CEO, Mr. Aalap Prajapati. An initial notice incorrectly stated his tenure as five years. The company confirmed the correct re-appointment period is for three years, from October 28, 2026, to October 27, 2029. Shareholders...
Gujarat Terce Laboratories Limited's Board of Directors met on 7 August 2026 and approved the financial results for the first quarter ended 30 June 2026. The company subsequently published extracts of these approved results in newspapers, including Business Standard and Jai Hind. This update is crucial for shareholders and potential...
Gujarat Terce Laboratories has announced its 41st Annual General Meeting will be held via Video Conferencing or Other Audio Visual Means. This digital format ensures widespread shareholder participation, reflecting a modern approach to corporate governance. The company is providing a remote e-voting facility, allowing all members to conveniently cast their...
Gujarat Terce Laboratories Limited received a certificate confirming its compliance regarding the processing of share dematerialization requests. The company has ensured that all securities received for dematerialization were duly confirmed with depositories and remain listed on the stock exchange. Physical share certificates received for dematerialization were cancelled, and shareholder records...
